ArticleScientific reports2025
Incidence and factor for acute acalculous cholecystitis during prolonged gastrointestinal disuse in external duodenal fistula.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
To investigate the incidence, risk factors, and outcomes of acute acalculous cholecystitis (AAC) following prolonged gastrointestinal disuse due to external duodenal fistula. This retrospective cohort study included adult patients with external duodenal fistula who experienced gastrointestinal tract disuse from January 2018 to January 2024. Patients were monitored until discharge or death. The primary outcome was the occurrence of AAC, while secondary outcomes included its treatment and prognosis. Of the enrolled 133 patients, 59 (44.4%) were diagnosed with AAC. The majority (79.7%) of AAC cases occurred during the reintroduction of enteral nutrition (EN). High SOFA score upon admission (Odds Ratio [OR] = 1.59, 95% Confidence Interval [CI]: 1.13-2.70, p = 0.005) and the vasopressor use upon admission (OR = 4.53, 95% CI: 1.09-19.22, p = 0.04) were associated with increased risk of AAC before EN reintroduction. For AAC occurring after EN reintroduction, the duration of intestinal disuse (OR = 1.06, 95% CI: 1.00-1.13, p = 0.04) was the sole risk factor. The incidence of AAC is notably high in patients undergoing prolonged gastrointestinal tract disuse, particularly after the reintroduction of Enteral Nutrition (EN) in patients with external duodenal fistula.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.